Personal outlays

Economy Term

Personal outlays refer to the total amount of money spent by individuals and households in a given period on goods and services, such as food, clothing, housing, education, healthcare, transportation, entertainment, and other personal expenses. Personal outlays are an essential component of the national economy, as they represent a significant portion of the Gross Domestic Product (GDP) and the overall consumer spending that drives economic growth.

The measurement of personal outlays is used as an indicator of consumer behavior and trends in the economy. It is also a critical factor in the calculation of inflation, as changes in personal outlays directly affect prices. For example, if consumers increase their spending on a particular product or service, it may lead to an increase in demand and, eventually, to an increase in prices. Similarly, if consumers reduce their spending, it can lead to a decrease in demand and a decrease in prices.

In the industry, understanding personal outlays helps businesses determine consumer tastes, preferences, and buying power. This information can be used to create targeted marketing campaigns and develop new products that meet consumer needs. Additionally, businesses can use data about personal outlays to adjust prices, optimize inventory levels, and predict future demand. Overall, personal outlays are essential for understanding the behavior of consumers and the health of the economy.




More Glossary Terms Beginning with P
  • Paediatric Exclusivity
    means, in the US, a six-month period of exclusivity to market a drug which is awarded by the FDA in return for certain paediatric clinical studies using that drug. This six-month period runs from the date of relevant patent expiry.
    Health Care Term Letter: P
  • Paid Development Method
    An actuarial method to estimate ultimate losses for a given cohort of claims such as an accident year/product line component. If the paid-to-date losses are then subtracted from the estimated ultimate losses, the result is an indication of the unpaid losses. The basic premise of the method is that cumulative paid losses for a given cohort of claims will grow in a stable, predictable pattern from y
    Insurance Term Letter: P
  • Panelboards
    Oriented strand board, particleboard, medium density fibreboard and plywood. Operating Statistics
    Manufacturing Term Letter: P
  • Partial Remission PR
    A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.
    Health Care Term Letter: P
  • Particleboard
    A panelboard produced by chemically bonding clean sawdust, small wood particles and recycled wood fibre under heat and pressure. Forestry & Wood Products Industry Operating Statistics
    Manufacturing Term Letter: P
  • Particulate Matter
    Total suspended particulate. A measure of the solid particles (wood, process dust and smoke) found in air emissions.
    Manufacturing Term Letter: P
  • Particulates
    Tiny particles of a substance.
    Manufacturing Term Letter: P
  • Passenger Load Factor
    Represents the total number of seats sold as a percentage of total seat capacity on all sectors flown. Airline Industry
    Transportation Term Letter: P
  • Passenger Mile Yield
    The amount of passenger revenue earned per revenue passenger mile during a reporting period Airline Industry
    Transportation Term Letter: P
  • Passenger revenue yield per Mile Average Yield per RPM
    Represents the average scheduled passenger fare revenue for each revenue passenger mile (RPM), or each mile a scheduled revenue passenger is flown. Airline Industry
    Transportation Term Letter: P
  • Passive Immunotherapy
    Immunologically active material transferred into the patient as a passive recipient. Monoclonal antibodies are considered Passive Immunotherapy since antibodies are generated outside the body and given to the patient
    Health Care Term Letter: P
  • Patent Term Extension
    means an extension of up to five years in the term of a US patent relating to a drug which compensates for delays in marketing resulting from the need to obtain FDA approval.
    Health Care Term Letter: P